The coronavirus (COVID-19) outbreak has disrupted the landscape for psoriasis treatment, making home phototherapy the only viable option for many patients.
Some doctors are not prescribing biologic treatment because of the risk of immunosuppression. The American Academy of Dermatology has issued guidance recommending against biologic treatment for patients at high risk for COVID-19. Additionally, the AAD advises physicians to carefully weigh the risks and benefits of biologic treatment for all other patients.1
Many phototherapy clinics have reduced or eliminated in-clinic treatment to lower the number of patients congregating in healthcare facilities.
At National Biological Corporation, our team is prepared to support patients who wish to purchase a home phototherapy unit. As a result of the pandemic, insurance plans that normally require patients to try clinical phototherapy first have agreed to waive the requirement.
Please note that as we continue operations, we are taking employee health and safety seriously. The vast majority of our administrative team is working from home. Our manufacturing and shipping facility is large enough so that workers can stand far more than 10 feet apart from one another.
1. “Guidance on the use of biologic agents during COVID-19 outbreak.” American Academy of Dermatology.